These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26301748)

  • 1. Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India.
    Deshmukh RD; Dhande DJ; Sachdeva KS; Sreenivas A; Kumar AM; Satyanarayana S; Parmar M; Moonan PK; Lo TQ
    PLoS One; 2015; 10(8):e0135802. PubMed ID: 26301748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons for loss to follow-up (LTFU) of pulmonary TB (PTB) patients: A qualitative study among Saharia, a particularly vulnerable tribal group of Madhya Pradesh, India.
    Mishra P; Sharma RK; Yadav R; Rao VG; Nigam S; Lingala MA; Bhat J
    PLoS One; 2021; 16(12):e0261152. PubMed ID: 34941885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social support a key factor for adherence to multidrug-resistant tuberculosis treatment.
    Deshmukh RD; Dhande DJ; Sachdeva KS; Sreenivas AN; Kumar AMV; Parmar M
    Indian J Tuberc; 2018 Jan; 65(1):41-47. PubMed ID: 29332647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do patients with DR-TB do not complete their treatment? Findings of a qualitative study from Pakistan.
    Abubakar M; Ullah M; Shaheen MA; Abdullah O
    BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon - a qualitative study exploring the experiences and perceptions of patients and healthcare professionals.
    McNally TW; de Wildt G; Meza G; Wiskin CMD
    BMC Health Serv Res; 2019 Aug; 19(1):594. PubMed ID: 31438958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of multidrug-resistant tuberculosis in Thailand.
    Maranetra KN
    Chemotherapy; 1996; 42 Suppl 3():10-5; discussion 30-3. PubMed ID: 8980862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant TB among previously treated TB cases: A retrospective study in Nagpur, India.
    Munje R; Deshmukh R; Tumane K
    Indian J Tuberc; 2015 Oct; 62(4):207-10. PubMed ID: 26970460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Better to Die Than Take These Medicines": A Community-Based Qualitative Study on the Determinants of Treatment Loss-to-Follow-Up in Tuberculosis Patients in District Faridabad, Haryana, India.
    Khaitan A; Rai SK; Krishnan A; Gupta SK; Kant S; Khilnani GC
    Cureus; 2022 May; 14(5):e25030. PubMed ID: 35591891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers.
    Thomas BE; Kumar JV; Periyasamy M; Khandewale AS; Hephzibah Mercy J; Raj EM; Kokila S; Walgude AS; Gaurkhede GR; Kumbhar JD; Ovung S; Paul M; Rajkumar BS; Subbaraman R
    J Med Internet Res; 2021 Jun; 23(6):e23294. PubMed ID: 34110300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological and behavioural correlates of drug-resistant tuberculosis in a Tertiary Care Centre, Delhi, India.
    Dzeyie KA; Basu S; Dikid T; Bhatnagar AK; Chauhan LS; Narain JP
    Indian J Tuberc; 2019 Jul; 66(3):331-336. PubMed ID: 31439176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Where there is hope: a qualitative study examining patients' adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan.
    Horter S; Stringer B; Greig J; Amangeldiev A; Tillashaikhov MN; Parpieva N; Tigay Z; du Cros P
    BMC Infect Dis; 2016 Jul; 16():362. PubMed ID: 27465783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study.
    Bieh KL; Weigel R; Smith H
    BMC Infect Dis; 2017 Jan; 17(1):50. PubMed ID: 28068907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China.
    Hutchison C; Khan MS; Yoong J; Lin X; Coker RJ
    BMC Public Health; 2017 Feb; 17(1):221. PubMed ID: 28222724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.
    Saldanha N; Runwal K; Ghanekar C; Gaikwad S; Sane S; Pujari S
    BMC Infect Dis; 2019 May; 19(1):391. PubMed ID: 31068153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the role of video direct observed therapy for patients on an oral short-course regimen for multi-drug resistant tuberculosis: findings from a qualitative study in Eswatini.
    Mukooza E; Schausberger B; Mmema N; Dlamini V; Aung A; Kerschberger B; Ciglenecki I; Vambe D; Wringe A
    BMC Infect Dis; 2024 Aug; 24(1):829. PubMed ID: 39148081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant tuberculosis patients lost to follow-up: self-reported readiness to restart treatment.
    Mangan JM; Tupasi TE; Garfin AM; Lofranco V; Orillaza-Chi R; Basilio R; Naval LC; Balane GI; Joson ES; Burt D; Lew WJ; Mantala M; Pancho S; Sarol JN; Golubkov A; Kurbatova EV
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1205-11. PubMed ID: 27510247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Home is where the patient is": a qualitative analysis of a patient-centred model of care for multi-drug resistant tuberculosis.
    Horter S; Stringer B; Reynolds L; Shoaib M; Kasozi S; Casas EC; Verputten M; du Cros P
    BMC Health Serv Res; 2014 Feb; 14():81. PubMed ID: 24559177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative exploration of tuberculosis patients who were lost to follow-up in Malaysia.
    Tok PSK; Wong LP; Liew SM; Razali A; Mahmood MI; Chinnayah T; Kawatsu L; Toha HR; Mohd Yusof K; Abd Rahman R; Che Mat Din SNA; Loganathan T
    PLoS One; 2023; 18(9):e0289222. PubMed ID: 37676902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects.
    Soedarsono S; Mertaniasih NM; Kusmiati T; Permatasari A; Juliasih NN; Hadi C; Alfian IN
    BMC Pulm Med; 2021 Nov; 21(1):360. PubMed ID: 34758794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.